Related Experiment Video
Updated: Jun 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
[Measles vaccine]
1Laboratory of Virus Infection, Kitasato Institute for Life Sciences. tetsuo-n@lisci.kitasato-u.ac.jp
Abstract:
Further attenuated live measles vaccine strains were developed through passages in chick embryo cells or other non-permissive cells from the Edmonston strain. The number of measles patients has reduced through worldwide acceptance of measles vaccine. Measles elimination was achieved in American continents and the goal of measles elimination in Western Pacific region was aimed by 2012. Recent development of molecular techniques facilitates the reverse genetics to recover the infectious virus from the cDNA clone constructed from measles RNA genome. Using this technology, characteristics of attenuated measles vaccine strain were investigated and new approach has started to develop the recombinant measles vaccine expressing foreign virus antigen(s) against the infectious diseases for which no effective vaccine is available. Besides infectious diseases, the oncolytic measles virus based on measles vaccine strains was developed for targeting cancer cells.
Insights
Measles vaccine development has reduced global measles cases. New recombinant vaccines and oncolytic measles virus offer future potential for infectious diseases and cancer therapy.
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Context:
- Measles vaccine development has significantly reduced global disease incidence.
- Measles elimination has been achieved in the Americas, with similar goals for other regions.
- Advances in molecular techniques, including reverse genetics, enable detailed investigation of viral strains.
Purpose:
- To investigate the characteristics of attenuated measles vaccine strains using reverse genetics.
- To develop novel recombinant measles vaccines expressing foreign antigens for unmet medical needs.
- To explore the potential of oncolytic measles virus for cancer therapy.
Summary:
- Attenuated measles vaccine strains were developed through cell culture passages.
- Reverse genetics technology allows for the recovery and analysis of infectious measles virus from cDNA.
- Research is ongoing to create recombinant measles vaccines for other infectious diseases and oncolytic measles virus for cancer treatment.
Impact:
- Successful measles vaccination campaigns have drastically reduced patient numbers worldwide.
- New vaccine strategies hold promise for combating infectious diseases lacking effective vaccines.
- Oncolytic measles virus presents a novel approach for targeted cancer cell therapy.
Related Concept Videos
Vaccinations
Vaccines
Respiratory Syncytial Virus Disease
Smallpox
Poliomyelitis
Chickenpox

